Johnson & Johnson Covid Vaccine Pause Continues After Experts Defer Vote

The shot has been given to some 7.2 million Americans, and participants at the meeting were told on Wednesday a seventh case involving a 28-year-old woman has been identified.

A pause on all US vaccinations with the Johnson & Johnson Covid shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a clotting disorder. The Centers for Disease Control and Prevention (CDC) convened a meeting a day after authorities reported six cases of women developing brain clots along with low blood platelet counts, including one death, within two weeks of people getting the one-dose Covid-19 vaccine.  The shot has been given to some 7.2 million Americans, and participants at the meeting were told on Wednesday a seventh case involving a 28-year-old woman has been identified. Wednesday's meeting could have decided whether to limit the vaccine to some subsets of the population, but most members said they were not yet comfortable in making that call without more data to study.